华邦健康
(002004)
| 流通市值：85.64亿 | | | 总市值：90.09亿 |
| 流通股本：18.82亿 | | | 总股本：19.80亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 5,945,032,088.09 | 2,820,969,309.75 | 11,664,669,783.79 | 8,909,836,679.88 |
| 营业收入 | 5,945,032,088.09 | 2,820,969,309.75 | 11,664,669,783.79 | 8,909,836,679.88 |
| 二、营业总成本 | 5,353,287,909.61 | 2,540,921,781.44 | 10,758,061,028.78 | 8,114,670,346.58 |
| 营业成本 | 3,787,991,698.41 | 1,773,938,403.36 | 7,683,859,359.93 | 5,629,798,504.13 |
| 税金及附加 | 64,633,224.23 | 31,911,391.88 | 129,149,704.88 | 98,976,738.22 |
| 销售费用 | 679,396,280.23 | 300,584,294.93 | 1,021,953,508.93 | 896,944,174.99 |
| 管理费用 | 514,113,021.04 | 272,086,044.31 | 1,277,742,199.4 | 953,561,648.45 |
| 研发费用 | 197,547,094.89 | 107,103,304.5 | 375,319,013.67 | 301,716,088.01 |
| 财务费用 | 109,606,590.81 | 55,298,342.46 | 270,037,241.97 | 233,673,192.78 |
| 其中:利息费用 | 153,155,858.38 | 73,001,380.1 | 349,974,105.54 | 263,838,241.88 |
| 其中:利息收入 | 27,473,174.78 | 13,272,465.01 | 69,659,912.52 | 48,493,362.3 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,734,211.26 | 622,260.29 | 3,097,277.73 | 922,533.86 |
| 加:投资收益 | 45,604,511.88 | 12,700,521.39 | -172,079,130.75 | -50,134,221.39 |
| 资产处置收益 | 12,005,319.65 | 2,978,628.75 | 3,752,750.93 | 3,888,656.97 |
| 资产减值损失(新) | -8,094,961.01 | 104,819.07 | -929,742,732.37 | -16,310,776.11 |
| 信用减值损失(新) | -18,666,523.13 | -5,682,820.22 | -33,629,022.75 | -6,869,990.29 |
| 其他收益 | 41,348,739.98 | 19,541,583.62 | 94,557,094.96 | 57,424,963.96 |
| 四、营业利润 | 666,675,477.11 | 310,312,521.21 | -127,435,007.24 | 784,087,500.3 |
| 加:营业外收入 | 32,436,279.1 | 1,122,512.21 | 12,929,819.42 | 6,690,304.94 |
| 减:营业外支出 | 8,160,387.23 | 1,791,342.25 | 46,001,995.43 | 22,332,641.06 |
| 五、利润总额 | 690,951,368.98 | 309,643,691.17 | -160,507,183.25 | 768,445,164.18 |
| 减:所得税费用 | 141,077,981.82 | 68,845,204.05 | 182,086,373.63 | 183,328,358.37 |
| 六、净利润 | 549,873,387.16 | 240,798,487.12 | -342,593,556.88 | 585,116,805.81 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 549,873,387.16 | 240,798,487.12 | -342,593,556.88 | 585,116,805.81 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 388,455,625.5 | 184,340,340.89 | -298,989,917.1 | 451,977,453.17 |
| 少数股东损益 | 161,417,761.66 | 56,458,146.23 | -43,603,639.78 | 133,139,352.64 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 0.09 | -0.15 | 0.23 |
| (二)稀释每股收益 | 0.2 | 0.09 | -0.15 | 0.23 |
| 八、其他综合收益 | 34,835,443.96 | 11,754,995.9 | -36,412,599.46 | -69,850,813.11 |
| 归属于母公司股东的其他综合收益 | 16,380,915.78 | 5,646,710.4 | -17,889,642.46 | -33,462,126.23 |
| 九、综合收益总额 | 584,708,831.12 | 252,553,483.02 | -379,006,156.34 | 515,265,992.7 |
| 归属于母公司股东的综合收益总额 | 404,836,541.28 | 189,987,051.29 | -316,879,559.56 | 418,515,326.94 |
| 归属于少数股东的综合收益总额 | 179,872,289.84 | 62,566,431.73 | -62,126,596.78 | 96,750,665.76 |
| 公告日期 | 2025-08-20 | 2025-04-23 | 2025-04-23 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |